Sampling time [Design Issues]

posted by Durga – India, 2018-08-14 07:37 (843 d 18:01 ago) – Posting: # 19167
Views: 2,546

We need to check the molecule available PK profile of drug (absorption, distribution and elimination). we need to read the guidelines how many sampling time points need to be set at different phases as per above mentioned.

you need to check the metabolite pharmacological activity (if applicable)

bases on the formulation also. it is also very important.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,240 posts in 4,431 threads, 1,482 registered users;
online 3 (1 registered, 2 guests [including 2 identified bots]).
Forum time: Saturday 00:38 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5